Y-Intercept (HK)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $793K | Buy |
6,318
+4,480
| +244% | +$563K | 0.02% | 1046 |
|
|
2025
Q1 | $252K | Sell |
1,838
-13,310
| -88% | -$1.82M | 0.02% | 960 |
|
|
2024
Q4 | $2.32M | Buy |
15,148
+7,970
| +111% | +$1.22M | 0.15% | 178 |
|
|
2024
Q3 | $1.39M | Buy |
7,178
+4,238
| +144% | +$821K | 0.09% | 309 |
|
|
2024
Q2 | $682K | Buy |
+2,940
| New | +$682K | 0.04% | 684 |
|
|
2023
Q2 | – | Sell |
-2,573
| Closed | -$715K | – | 1278 |
|
|
2023
Q1 | $715K | Sell |
2,573
-3,729
| -59% | -$1.04M | 0.08% | 373 |
|
|
2022
Q4 | $1.75M | Buy |
6,302
+3,458
| +122% | +$958K | 0.26% | 73 |
|
|
2022
Q3 | $759K | Buy |
+2,844
| New | +$759K | 0.08% | 385 |
|
|
2022
Q2 | – | Sell |
-2,882
| Closed | -$607K | – | 868 |
|
|
2022
Q1 | $607K | Buy |
2,882
+185
| +7% | +$39K | 0.14% | 203 |
|
|
2021
Q4 | $647K | Buy |
2,697
+1,164
| +76% | +$279K | 0.15% | 190 |
|
|
2021
Q3 | $434K | Sell |
1,533
-12,298
| -89% | -$3.48M | 0.08% | 369 |
|
|
2021
Q2 | $4.79M | Buy |
13,831
+11,168
| +419% | +$3.87M | 1.22% | 4 |
|
|
2021
Q1 | $735K | Buy |
+2,663
| New | +$735K | 0.2% | 157 |
|